Monthly Investment Updates

The year 2025 challenged many of the assumptions investors carried into January. The pace of rate cuts, the durability of the labor market, the influence of artificial intelligence on productivity, and the resilience of corporate earnings all shifted throughout the year. Even with these changes, markets adapted and pushed forward.

As we close out the year, we are looking back at what changed and asking an important question: Is this the new normal?

Markets advanced through policy shifts, economic crosscurrents, and persistent headline noise. Throughout these transitions, our focus remained on discipline, strategy, and long term decision making.

October continued the market’s upward trajectory, rewarding investors who maintained discipline through a year of volatility. U.S. equities posted another month of solid gains, with technology and healthcare leading the charge. The S&P 500 and Nasdaq Composite both extended their positive momentum, while small-caps regained footing after uneven performance earlier in the year.
Our investment team maintained existing allocations with one key change, we have sold our position in Materials, reallocating that exposure back into our core holdings. We continue to hold allocations to Healthcare and Biotech, sectors that remain supported by strong innovation trends, attractive valuations, and steady demand through various economic environments.

September is a month of transitions; kids head back to school, football season kicks off, and routines start to feel a little more grounded again. It’s also a reminder that preparation matters. Just as students sharpen pencils and athletes review their playbooks, our investment team stays disciplined and prepared for whatever the next quarter brings. That preparation and long-term focus are what help keep your financial plan on track, no matter the headlines.

Strategic Advisory Partners’ July 2025 Investment Update highlights a powerful market rally, with the S&P 500 and Nasdaq Composite both hitting new all-time highs in June and the Dow Jones Industrial Average up 4.3%. Fueled by strong corporate earnings, easing geopolitical tensions, and solid labor‐market data, this momentum has brought equity levels back to February highs. To capitalize on emerging opportunities, we’ve increased discretionary allocations to Materials and Healthcare while modestly trimming Industrials—maintaining our core exposure to large‐ and small‐cap U.S. stocks and fixed income for balanced, long‐term growth.

May delivered a modest but meaningful rebound across major U.S. equity indices, reflecting cautious optimism despite persistent underlying risks. Market sentiment improved somewhat as investors processed a mix of corporate earnings reports and macroeconomic data, though uncertainty remains a defining feature of the current investment environment.

April witnessed a mixed performance across major U.S. stock indices. While there was a late-month rally, the overall trend highlighted the volatility our CIO noted. It’s important to remember that periods of rapid market increases can occur even within broader, longer-term market declines. This underscores the need for a consistent and disciplined investment strategy, particularly in the current environment characterized by heightened sensitivity to news and increased overall market risk.